BioMarin Pharmaceutical Inc (BMRN): Price and Financial Metrics
BMRN Price/Volume Stats
| Current price | $55.27 | 52-week high | $94.85 |
| Prev. close | $56.11 | 52-week low | $52.93 |
| Day low | $55.15 | Volume | 2,539,700 |
| Day high | $56.35 | Avg. volume | 1,800,056 |
| 50-day MA | $60.94 | Dividend yield | N/A |
| 200-day MA | $67.71 | Market Cap | 10.60B |
BMRN Stock Price Chart Interactive Chart >
BioMarin Pharmaceutical Inc (BMRN) Company Bio
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU). (Source:Wikipedia)
BMRN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BMRN Price Returns
| 1-mo | -6.83% |
| 3-mo | -23.48% |
| 6-mo | -17.19% |
| 1-year | -31.64% |
| 3-year | -29.32% |
| 5-year | -47.76% |
| YTD | -15.91% |
| 2024 | -31.83% |
| 2023 | -6.83% |
| 2022 | 17.14% |
| 2021 | 0.75% |
| 2020 | 3.71% |